Journal of Neurology

, Volume 243, Issue 9, pp 648–651

Mitochondrial DNA levels in the brain of HIV-positive patients after zidovudine therapy

  • F. D. Davison
  • B. J. Sweeney
  • F. Scaravilli
Original Communication

Abstract

Previous studies have shown that the antiviral nucleoside analogue zidovudine (AZT) depletes levels of mitochondrial DNA (mtDNA) in muscle of patients on long-term therapy. In this study we found that in a similar group of eight HIV-positive patients receiving AZT there was no depletion of brain mtDNA. This finding suggests that AZT related mtDNA depletion is not a contributing factor in the HIV encephalopathy that occurs in a proportion of HIV positive patients receiving this antiviral agent.

Key words

Mitochondrial DNA Human immunodeficiency virus Zidovudine Dementia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    An S-F, Ciardi A, Scaravilli F (1994) PCR detection of HIV proviral DNA in the brains of AIDS patients: comparison between results using fresh frozen and paraffin embedded specimens. J Clin Pathol 47:990–994Google Scholar
  2. 2.
    Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:508–510Google Scholar
  3. 3.
    Bebenek K, Thomas DC, Roberts JD, Eckstein F, Kunkel TA (1993) Effects of AZT metabolites on simian virus 40 origin-dependent replication and heteroduplex repair in HeLa cell extracts. Mol Pharmacol 43:57–63Google Scholar
  4. 4.
    Chalmers AC, Greco CM, Miller RG (1991) Progress in AZT myopathy. Neurology 41:1181–1184Google Scholar
  5. 5.
    Dalakas MC, Illa I, Pezeshkpour GH, Lankaitis JP, Cohen BC, Griffin JL (1990) Long term therapy with AZT can cause mitochondrial myopathy indistinguishable from myopathy associated with HIV. N Engl J Med 322:1098–1105Google Scholar
  6. 6.
    Eymard B, Hauw J-J (1992) Mitochondrial encephalopathies. Curr Opim Neurol Neurosurg 5:909–916Google Scholar
  7. 7.
    Gillespie D, Habbell HR, Carter WA, et al (1994) Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U) without synergistic toxicity to bone marrow progenitor cell elements In Vivo 8:375–381Google Scholar
  8. 8.
    Gray F, Geny C, Dournon E, Fenelon G, Lionnet F, Gherardi R (1991) Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain. Lancet 337:852–853Google Scholar
  9. 9.
    Gross NJ, Getz GS, Rabinowitz M (1969) Apparent turnover of mitochondrial DNA and phospholipids in the tissues of the rat. J Biol Chem 244:1552–1556Google Scholar
  10. 10.
    Hayakawa M, Ogawa T, Sugiyama S, Tanaka M, Ozawa T (1991) Massive conversion of guanosine to 8-hydroxyguanosine in mouse liver mitochondrial DNA by administration of AZT. Biochem Biophys Res Commun 176: 87–93Google Scholar
  11. 11.
    Lewis W, Dalakas MC (1993) Mitochondrial cytotoxicity of antiviral drugs. Nature Med 1:417–422Google Scholar
  12. 12.
    Sato M, Murao K, Mizobuchi M, Takahara J (1993) Quantitative and sensitive northern blot hybridisation using PCR-generated DNA probes labelled with digoxigenin by nick translation. Biotechniques 15:880–882Google Scholar
  13. 13.
    Sidtis JL, Gatsonis G, Price RW, et al (1993) Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann Neurol 33:343–349Google Scholar
  14. 14.
    Simpson MV, Chin CD, Keilbaugh SA, Lin T-S, Prusoff WH (1989) Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogues which inhibit HIV-1 replication. Biochem Pharmacol 38:1033–1036Google Scholar
  15. 15.
    Swartz MN (1995) Mitochondrial toxicity - new adverse drug affects. N Engl J Med 333:1146–1148Google Scholar
  16. 16.
    Tritschler HJ, Andretta F, Moraes CT, et al (1992) Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 42: 209–217Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • F. D. Davison
    • 1
  • B. J. Sweeney
    • 2
  • F. Scaravilli
    • 1
  1. 1.Department of NeuropathologyInstitute of NeurologyLondonUK
  2. 2.Department of Clinical NeurologySt. Mary's HospitalLondonUK

Personalised recommendations